𝔖 Bobbio Scriptorium

✦ LIBER ✦

STATIN THERAPY IS COST-EFFECTIVE FOR VASCULAR EVENT PREVENTION IN ADULTS WITH ELEVATED C-REACTIVE PROTEIN: IMPLICATIONS OF JUPITER

✍ Scribed by Slejko, Julia F.; Page, Robert L.; Sullivan, Patrick W.

Book ID: 122366081
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 62 KB
Volume: 55
Category: Article
ISSN: 1558-3597
DOI: 10.1016/S0735-1097(10)61230-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Influence and Critique of the JUPITER Tr

Influence and Critique of the JUPITER Trial (Statins v No Statins for Primary Prevention of Cardiovascular Events in Patients with Normal Lipids and Elevated C-Reactive Protein)

✍ Russell H. Samson; Deepak G. Nair 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 256 KB

PCV72 COST-EFFECTIVENESS OF ROSUVASTATIN

PCV72 COST-EFFECTIVENESS OF ROSUVASTATIN FOR THE PRIMARY PREVENTION OF VASCULAR EVENTS ACCORDING TO FRAMINGHAM RISK SCORE IN PATIENTS WITH AN ELEVATED C-REACTIVE PROTEIN

✍ GP MacDonald 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB

Baseline Characteristics of Participants

Baseline Characteristics of Participants in the JUPITER Trial, A Randomized Placebo-Controlled Primary Prevention Trial of Statin Therapy Among Individuals With Low Low-Density Lipoprotein Cholesterol and Elevated High-Sensitivity C-Reactive Protein

✍ Paul M. Ridker; Francisco A.H. Fonseca; Jacques Genest; Antonio M. Gotto; John J 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 119 KB

Prevalence of Low Low-Density Lipoprotei

Prevalence of Low Low-Density Lipoprotein Cholesterol With Elevated High Sensitivity C-Reactive Protein in the U.S.: Implications of the JUPITER (Justification for the Use of Statins in Primary Prevention: An Intervention Trial Evaluating Rosuvastatin) Study

✍ Erin D. Michos; Roger S. Blumenthal 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 196 KB

Efficacy of Rosuvastatin Among Men and W

Efficacy of Rosuvastatin Among Men and Women With Moderate Chronic Kidney Disease and Elevated High-Sensitivity C-Reactive Protein: A Secondary Analysis From the JUPITER (Justification for the Use of Statins in Prevention–an Intervention Trial Evaluating Rosuvastatin) Trial

✍ Paul M. Ridker; Jean MacFadyen; Michael Cressman; Robert J. Glynn 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 502 KB